Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1993 1
1994 1
2002 1
2004 2
2005 4
2006 8
2007 6
2008 9
2009 6
2010 14
2011 19
2012 18
2013 25
2014 35
2015 35
2016 34
2017 34
2018 34
2019 28
2020 67
2021 61
2022 95
2023 72
2024 67
2025 70
2026 23

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

670 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Did you mean ct non alcoholic fatty liver disease (927 results)?
Vitamin E for people with non-alcoholic fatty liver disease.
Wen H, Deng H, Yang L, Li L, Lin J, Zheng P, Bjelakovic M, Ji G. Wen H, et al. Cochrane Database Syst Rev. 2024 Oct 16;10(10):CD015033. doi: 10.1002/14651858.CD015033.pub2. Cochrane Database Syst Rev. 2024. PMID: 39412049 Free PMC article.
RATIONALE: Non-alcoholic fatty liver disease (NAFLD), recently renamed metabolic dysfunction-associated steatotic liver disease (MASLD), is the most common liver disease worldwide, affecting an estimated 3 in 10 peopl …
RATIONALE: Non-alcoholic fatty liver disease (NAFLD), recently renamed metabolic dysfunction-associated s …
Does the Mediterranean Diet Have Any Effect on Lipid Profile, Central Obesity and Liver Enzymes in Non-Alcoholic Fatty Liver Disease (NAFLD) Subjects? A Systematic Review and Meta-Analysis of Randomized Control Trials.
Del Bo' C, Perna S, Allehdan S, Rafique A, Saad S, AlGhareeb F, Rondanelli M, Tayyem RF, Marino M, Martini D, Riso P. Del Bo' C, et al. Nutrients. 2023 May 9;15(10):2250. doi: 10.3390/nu15102250. Nutrients. 2023. PMID: 37242133 Free PMC article.
The effectiveness of the Mediterranean diet (MD) in non-alcoholic fatty liver disease (NAFLD) subjects has been evaluated in several randomized controlled trials (RCTs). ...RCTs with NAFLD subjects were included in this systematic review with a …
The effectiveness of the Mediterranean diet (MD) in non-alcoholic fatty liver disease (NAFLD) subjects ha …
Biomarkers of liver diseases.
Tamber SS, Bansal P, Sharma S, Singh RB, Sharma R. Tamber SS, et al. Mol Biol Rep. 2023 Sep;50(9):7815-7823. doi: 10.1007/s11033-023-08666-0. Epub 2023 Jul 24. Mol Biol Rep. 2023. PMID: 37482588 Review.
Various disorders such as non-alcoholic fatty liver disease, fibrosis, cirrhosis, hepatocellular carcinoma, and hepatitis are associated with improper functions of the liver. ...They are not, however, unique to the liver; hence, ef …
Various disorders such as non-alcoholic fatty liver disease, fibrosis, cirrhosis, hepatocellular carcinom …
The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease.
Ryan MC, Itsiopoulos C, Thodis T, Ward G, Trost N, Hofferberth S, O'Dea K, Desmond PV, Johnson NA, Wilson AM. Ryan MC, et al. J Hepatol. 2013 Jul;59(1):138-43. doi: 10.1016/j.jhep.2013.02.012. Epub 2013 Feb 26. J Hepatol. 2013. PMID: 23485520 Clinical Trial.
BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) affects up to 30% of the population and signifies increased risk of liver fibrosis and cirrhosis, type 2 diabetes, and cardiovascular disease. ...We aimed at examinin …
BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD) affects up to 30% of the population and …
The effect of a fruit-rich diet on liver biomarkers, insulin resistance, and lipid profile in patients with non-alcoholic fatty liver disease: a randomized clinical trial.
Alami F, Alizadeh M, Shateri K. Alami F, et al. Scand J Gastroenterol. 2022 Oct;57(10):1238-1249. doi: 10.1080/00365521.2022.2071109. Epub 2022 Jun 16. Scand J Gastroenterol. 2022. PMID: 35710164 Clinical Trial.
BACKGROUND: Despite confirmed dietary approaches to improve the Non-Alcoholic Fatty Liver Disease (NAFLD), the effect of fruits on NAFLD is not clear. The present study aimed to investigate the effect of a fruit rich diet (FRD) on liver s …
BACKGROUND: Despite confirmed dietary approaches to improve the Non-Alcoholic Fatty Liver Disease (NAFLD) …
New targets for NAFLD.
Parlati L, Régnier M, Guillou H, Postic C. Parlati L, et al. JHEP Rep. 2021 Aug 8;3(6):100346. doi: 10.1016/j.jhepr.2021.100346. eCollection 2021 Dec. JHEP Rep. 2021. PMID: 34667947 Free PMC article. Review.
Non-alcoholic fatty liver disease (NAFLD) is a growing cause of chronic liver disease worldwide. It is characterised by steatosis, liver inflammation, hepatocellular injury and progressive fibrosis. Several preclinical model …
Non-alcoholic fatty liver disease (NAFLD) is a growing cause of chronic liver disease world …
Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study.
Tan EX, Lee JW, Jumat NH, Chan WK, Treeprasertsuk S, Goh GB, Fan JG, Song MJ, Charatcharoenwitthaya P, Duseja A, Imajo K, Nakajima A, Seki Y, Kasama K, Kakizaki S, Lesmana LA, Zheng KI, Zheng MH, Koh CJ, Ho KY, Goh KL, Wong VW, Dan YY. Tan EX, et al. Metabolism. 2022 Jan;126:154911. doi: 10.1016/j.metabol.2021.154911. Epub 2021 Oct 12. Metabolism. 2022. PMID: 34648769 Free article.
BACKGROUND: A significant proportion of the non-alcoholic fatty liver disease (NAFLD) population is non-obese. Prior studies reporting the severity of NAFLD amongst non-obese patients were heterogenous. ...Serum GGT, cholest …
BACKGROUND: A significant proportion of the non-alcoholic fatty liver disease (NAFLD) population is no …
Non-alcoholic fatty liver disease and risk of type 2 diabetes.
Lallukka S, Yki-Järvinen H. Lallukka S, et al. Best Pract Res Clin Endocrinol Metab. 2016 Jun;30(3):385-95. doi: 10.1016/j.beem.2016.06.006. Epub 2016 Jun 23. Best Pract Res Clin Endocrinol Metab. 2016. PMID: 27432073 Review.
Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of liver disease from simple steatosis to non-alcoholic steatohepatitis (NASH) and cirrhosis. ...NAFLD was a predictor of T2DM in all 14 studies where NAFLD …
Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of liver disease from simple st …
Statin liver safety in non-alcoholic fatty liver disease: A systematic review and metanalysis.
Pastori D, Pani A, Di Rocco A, Menichelli D, Gazzaniga G, Farcomeni A, D'Erasmo L, Angelico F, Del Ben M, Baratta F. Pastori D, et al. Br J Clin Pharmacol. 2022 Feb;88(2):441-451. doi: 10.1111/bcp.14943. Epub 2021 Jun 28. Br J Clin Pharmacol. 2022. PMID: 34133035 Free PMC article.
AIMS: Statin liver safety in non-alcoholic fatty liver disease (NAFLD) patients is not well defined. We analysed differences in liver function tests, including alanine transaminase aminotransferase (ALT), aspartate transaminase (AS …
AIMS: Statin liver safety in non-alcoholic fatty liver disease (NAFLD) patients is not well define …
Vitamin E in paediatric non-alcoholic fatty liver disease: a meta-analysis.
Lin M, Zeng H, Deng G, Lei J, Li J. Lin M, et al. Clin Res Hepatol Gastroenterol. 2021 May;45(3):101530. doi: 10.1016/j.clinre.2020.08.008. Epub 2020 Dec 4. Clin Res Hepatol Gastroenterol. 2021. PMID: 33272889
AIMS: There is currently no specific treatment for non-alcoholic fatty liver disease (NAFLD) in children, but recent studies have shown that vitamin E may be effective. ...CONCLUSIONS: Vitamin E therapy can improve blood lipids to some extent, b …
AIMS: There is currently no specific treatment for non-alcoholic fatty liver disease (NAFLD) in children, …
670 results